

AI in Bio @NeurIPS
Co-hosted by Scienta Lab, BioLabs and Orakl Oncology
NeurIPS 2026 comes to Paris, and with it some of the brightest minds in machine learning. More and more of them are turning to biology and medicine, and AI is starting to change how we discover and develop drugs.
Scienta Lab, BioLabs and Orakl Oncology are bringing them together for an afterwork at the Hôtel-Dieu, in the heart of Paris, alongside the AI, biotech and health communities: researchers, computational biologists, biotech and pharma teams, founders and investors.
On the program: the official launch of PRIMO
PRIMO (Patient Representations in Multi-Omics) is an open benchmark that measures whether omics AI actually helps develop drugs, from target to clinic. Most existing benchmarks evaluate models on cells and technical quality. PRIMO evaluates them on the patient-level tasks that matter for drug development: treatment response, prognosis, clinical scores and disease endotypes. Its first leaderboard covers 70 tasks across 50 cohorts and more than 5,000 patients.
PRIMO was launched by Scienta Lab in partnership with Orakl Oncology, Hugging Face and MICS (CentraleSupélec).
🔗PRIMO
Join us
Whether you want to exchange ideas, meet the teams behind PRIMO or simply connect with the AI x bio community, register below. The event is open to all, but spots are limited.
How to find us
Go to 1 Parvis de Notre-Dame, 75004 Paris
Enter the building and turn right
Walk down the corridor all the way to the end
Go up to the 3rd floor
Step onto the walkway and head to the first door